why choose us

First received: July 19, 2022

Clinical Trial: A North Macedonian Study Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participanta With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting

Study Status: Completed

Recruit Status: Completed

Condition: Diabetes Mellitus, Type 2

Study Type: Observational


Official Title: A Multicentre, Single-arm, Retrospective Study Investigating Glycaemic Control in GLP-1 Naive Participants With Type 2 Diabetes Who Initiated Once-weekly Semaglutide (OZEMPIC) in a Real World Setting

Brief Summary: The purpose of this study is to investigate glycaemic control and other clinical parameters in glucagon like peptide -1 (GLP-1) naive adult participants with type 2 diabetes (T2D) who initiated once weekly (OW) semaglutide in local clinical practice in North Macedonia. The participants were treated according to current clinical practice, applicable local labels, and standard of care as per physicians' discretion. The total duration of the study is planned to be approximately 30 weeks which is the period from OW…

Read more